Stay updated on Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check12 days agoChange DetectedThe record for the completed phase 2b GB0139 trial for idiopathic pulmonary fibrosis is displayed, including its study design, eligibility criteria, outcomes, locations, dates, and study documents.SummaryDifference100%

- Check19 days agoChange DetectedThe footer’s revision label changes from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check33 days agoChange DetectedA general NIH notice about the terminology transition appears above the ClinicalTrials.gov error page, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record and its content. This blocks access to essential study information and shows a Home option.SummaryDifference18%

Stay in the know with updates to Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled GB0139 for Idiopathic Pulmonary Fibrosis Clinical Trial page.